top of page
On 12 October 2023, the Danish Life Science Cluster, Nordic Life Science Partners, and the Lecheng Administration signed a Strategic Cooperation Agreement in Copenhagen within health and life science that was witnessed by Ms. XIE Jing, Vice Governor of Hainan Province.
Nordic Life Science Platform - Fast-track China Entry
China Market Access via Fast-track Approvals for CE/FDA approved Medtech, Healthtech, Drugs, and Rehabilitation Equipment at Hainan Boao Lecheng International Medical Tourism Pilot Zone and Guangdong-Hong Kong-Macao Great Bay Area
About Us - Mission
About Us - Purpose & Mission
The Nordic Life Science Platform (NLSP) gives Nordic / European Life Science companies a more safe, efficient, and easier access to the rapidly expanding Chinese healthcare market by taking advantage of the preferential policies and opportunities at Hainan Boao Lecheng International Medical Tourism Pilot Zone (HBL) and Guangdong-Hong Kong-Macao Great Bay Area (GBA).
We match the demand for innovative medical devices, drugs, and rehabilitation equipment by the currently 25 hospitals at HBL and the currently 45 designated hospitals in GBA with the supply of Nordic / European life science companies for the benefit of Chinese patients, and that way help access and develop new sales/ export opportunities in China.
Through the NLSP Step-by-Step Market Entry Model, HBL and GBA can serve as gateways and stepping-stones to the rest of the Chinese Healthcare Market.
To explore the market opportunities in China further, the Nordic Life Science Partners ApS has established a Partnership with the Danish Life Science Cluster.
China Office
Room 2003, Level 20, 989 Changle Road, Xuhui, Shanghai 200031, China
Mobile: +86 136 1169 1358 and Email: info@nlsp.dk
Nordic Office
Lyngby Hovedgade 17, 2. th, 2800 Kgs. Lyngby, Denmark
Mobile: +45 2530 8027 and Email: info@nlsp.dk
bottom of page